Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • HIV Protease
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

biotin tat (47 57)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | Activity
  • Peptide Products
    12
    TargetMol | inventory
Biotin-TAT (47-57)
T386171231898-25-1
Biotin-TAT (47-57) is a biotin-tagged transactivator of transcription, commonly employed as a protein transduction domain (PTD) in various primary cells. Its transduction capacity is contingent on ATP and temperature, suggesting the participation of endocytosis.
  • Inquiry Price
Size
QTY
Biotin-TAT (47-57) acetate
T38617L
Biotin-TAT (47-57) acetate is a biotin-labeled TAT polypeptide and a transactivator of transcription. Biotin-TAT (47-57) acetate is one of the most widely used peptides in protein transduction domains.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Cys-TAT(47-57) acetate(583836-55-9 Free base)
TP1185L
Cys-TAT(47-57) acetate is derived from the HIV-1 transactivating protein. Cys-TAT(47-57) acetate is an arginine rich peptide that can penetrate cells.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TAT (48-57) TFA(253141-50-3,free)
TP1689
TAT (48-57) (TFA) is a cellular permeability peptide derived from hiv-1 transcriptional activator (TAT) protein residue 48-57.
  • $63
Backorder
Size
QTY
TAT (48-57) (TFA)
T75983
TAT (48-57) (TFA) is a cell-penetrating peptide obtained from residues 48-57 of the HIV-1 Tat (transactivator of transcription) protein.
  • Inquiry Price
Size
QTY
TAT (48-57)
TP1744253141-50-3
TAT (48-57) is a cell-permeable peptide derived from the HIV-1 transactivator of transcription (Tat) protein, encompassing amino acid residues 48 to 57 from the basic domain of HIV Tat.
  • $63
Backorder
Size
QTY
(Cys47)-HIV-1 tat Protein (47-57)
T40719627079-23-6
(Cys47)-HIV-1 tat Protein (47-57) possesses membrane translocation functionality and can serve as a surface derivatization agent for magnetic pharmaceuticals, enhancing their uptake into specific target cells.
  • Inquiry Price
Size
QTY
Cys-TAT(47-57)
TP1185583836-55-9
Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) is an arginine-rich cell-penetrating peptide derived from the HIV-1 transactivating protein, corresponding to the protein transduction domain of the TAT protein.
  • Inquiry Price
Size
QTY
FITC-LC-TAT (47-57)
T76554
FITC-LC-TAT (47-57), a fluorescein isothiocyanate (FITC)-labeled trans-activator of transcription (TAT) peptide, is recognized as a cell-penetrating peptide (CPP) and enhances the yield and solubility of heterologous proteins [1].
  • Inquiry Price
Size
QTY
TAT (47-57), FAM-labeled
T765521676104-81-6
TAT (47-57), FAM-labeled, is a cell-penetrating peptide (CPP) with significant potential for intracellular drug delivery research [1].
  • Inquiry Price
Size
QTY
TAT (47-57) GGG-Cys(Npys)
T765531231898-26-2
TAT (47-57) GGG-Cys(Npys) is a cell-penetrating peptide (CPP) with potential applications in intracellular drug delivery research [1].
  • Inquiry Price
Size
QTY
Cys(Npys)-TAT (47-57)
T76545
Cys(Npys)-TAT (47-57), a peptide fragment corresponding to the transduction domain of the TAT peptide, contains an activated cysteine residue C and can electrostatically interact with plasmid DNA. Notably, TAT is a small nuclear transcriptional activator protein encoded by HIV-1 [1].
  • Inquiry Price
Size
QTY